NASDAQ: ANIK
$37.72
- 0.05 (0.13%)
Volume: 187,600
4:00 PM ET on Oct 22, 2014
Delayed at least 20 minutes.

Investor Relations

Headquartered in Bedford, Massachusetts, Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. Our proprietary technology is based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body that is essential to joint health and tissue function. Anika’s products range from orthopedic/joint health solutions led by Orthovisc® and Monovisc®, our multi- and single-injection treatments for osteoarthritis of the knee, to surgical aids in the ophthalmic and anti-adhesion fields. The company also offers aesthetic dermal fillers for the correction of facial wrinkles. Anika’s Italian subsidiary, Anika Therapeutics S.r.l., provides a complimentary product and technology portfolio comprised of HA-based products in the orthopedics/joint health, advanced wound care and ear, nose and throat fields. Anika’s technology portfolio, including Anika Therapeutics S.r.l.’s subsidiary’s regenerative tissue technology, advances the company’s vision to offer therapeutic products that go beyond pain management to protect and restore damaged tissue. The company’s approach has enabled Anika to deliver long-term shareholder value by providing profitability and positive cash-flow, two rare characteristics for an entrepreneurial small-cap company that Anika intends to retain as it grows in the industry.

 News Releases

News Releases

View recent and archived news releases on acquisitions, earnings, events and general company news

Corporate Governance

Corporate Governance

View recent and archived news releases on acquisitions, earnings, events and general company news

 Webcasts & Presentations

Webcasts & Presentations

Listen to quarterly earnings calls and investor conference presentations.

Quarterly Results

Financial Results

Download quarterly earnings releases and other related documents.

 SEC Filings

SEC Filings

Download reader-friendly documents and access all SEC filings.

Stock Information

Stock Information

Access stock quotes and charts.